Death causes six-month delay of trial in Merck, Pfizer vaccine patent dispute

Intellectual Property 2021-02-03 5:18 pm By Miklos Bolza Sydney

Please login to bookmark

The Federal Court has delayed a 15-day hearing in a pneumococcal vaccine patent dispute between Merck Sharp & Dohme and Pfizer after the sudden death of a family member of one of Pfizer’s expert witnesses.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au